The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing lethal acute respiratory disease emerged in December 2019. The World Health Organization named this disease “COVID-19” and declared it a pandemic on March 11, 2020. Many studies have shown that mesenchymal stem cells (MSCs) a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Stem Cells Int
Main Authors: Alzahrani, Faisal A., Saadeldin, Islam M., Ahmad, Abrar, Kumar, Dipak, Azhar, Esam I., Siddiqui, Arif Jamal, Kurdi, Bassem, Sajini, Abdulrahim, Alrefaei, Abdulmajeed F., Jahan, Sadaf
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2020
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7512102/
https://ncbi.nlm.nih.gov/pubmed/33014070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8835986
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares